Cardinal Health, Inc. (NYSE:CAH) Holdings Cut by Cognios Beta Neutral Large Cap Fund LP

Cognios Beta Neutral Large Cap Fund LP reduced its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 10.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,629 shares of the company’s stock after selling 671 shares during the period. Cognios Beta Neutral Large Cap Fund LP’s holdings in Cardinal Health were worth $567,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of CAH. Alaska Permanent Fund Corp lifted its stake in shares of Cardinal Health by 38.0% in the 4th quarter. Alaska Permanent Fund Corp now owns 21,095 shares of the company’s stock valued at $2,126,000 after purchasing an additional 5,804 shares during the last quarter. GAMMA Investing LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at $135,000. Linden Thomas Advisory Services LLC increased its stake in Cardinal Health by 10.5% in the fourth quarter. Linden Thomas Advisory Services LLC now owns 10,960 shares of the company’s stock valued at $1,105,000 after acquiring an additional 1,045 shares during the period. Community Bank & Trust Waco Texas acquired a new position in Cardinal Health in the fourth quarter worth about $515,000. Finally, Larson Financial Group LLC lifted its stake in Cardinal Health by 52.8% during the fourth quarter. Larson Financial Group LLC now owns 1,930 shares of the company’s stock worth $195,000 after purchasing an additional 667 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. TheStreet lowered Cardinal Health from a “b-” rating to a “c+” rating in a research note on Wednesday, December 27th. UBS Group increased their price target on Cardinal Health from $122.00 to $125.00 and gave the stock a “buy” rating in a research report on Monday, February 5th. SVB Leerink started coverage on Cardinal Health in a research report on Monday, February 26th. They issued an “outperform” rating and a $125.00 price objective for the company. Argus raised shares of Cardinal Health from a “hold” rating to a “buy” rating in a research note on Friday, February 9th. Finally, Barclays assumed coverage on Cardinal Health in a research note on Wednesday, January 3rd. They set an “overweight” rating and a $117.00 price objective for the company. One research analyst has rated the stock with a sell rating, three have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $103.07.

Cardinal Health Price Performance

NYSE:CAH traded up $0.16 on Wednesday, reaching $103.54. 2,057,471 shares of the company’s stock were exchanged, compared to its average volume of 2,274,126. Cardinal Health, Inc. has a 52 week low of $77.56 and a 52 week high of $116.04. The stock has a fifty day simple moving average of $109.56 and a 200-day simple moving average of $104.59. The firm has a market cap of $25.18 billion, a price-to-earnings ratio of 40.76, a P/E/G ratio of 0.99 and a beta of 0.68.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, February 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.56 by $0.26. The company had revenue of $57.45 billion during the quarter, compared to the consensus estimate of $57.02 billion. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The firm’s revenue was up 11.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.32 EPS. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 7.28 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were issued a dividend of $0.5006 per share. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.93%. Cardinal Health’s dividend payout ratio (DPR) is 78.74%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.